← Tra cứu cổ phiếu

iShareInvest Research

HNX · Quý 2/2026

AMV

Sản xuất Kinh doanh Dược và Trang thiết bị Y tế Việt Mỹ

Analysis of business results & financial statements · Quý 2/2026

▼▼ Declining sharply

Trailing net profit reached 49.3bn, fell 118.1bn compared with the same period last year. Offsetting pressure came mainly from higher administrative expenses, lower gross profit, weaker other profit, and higher finance costs. Detailed impact is shown below:

See what is changing ↓
P/E
-3.05x
P/B
0.10x
EPS
-394
BVPS
11,889
ROE
-3.1%
ROA
-2.6%
Market price
1,200
16 Oct 2026

What Is Changing

On a TTM 2026Q2 basis, AMV posted a very sharp profit drop versus the same period, showing that pressure has clearly fed through to the bottom line — margins have been compressing consistently over multiple periods. More notably, a significant portion of profit is supported by non-core sources, further affecting earnings quality.

Profit bridge

Vs last year · TTM

  1. Other
  2. Administrative expenses
  3. Gross profit
  4. Other profit
  5. Finance costs
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 2/2026

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue37.47.239.512.738.363.6222.75.7
LNST-27.4-8.2-3.3-10.9-37.6-3.467.345.3
Net margin-73.33%-114.01%-8.33%-85.59%-98.25%-5.33%30.21%793.92%

Revenue

37bn

Net income

-27bn

Net margin

-73.33%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins are under pressure while earnings still rely significantly on non-core sources.

Revenue Growth

▼▼

Is growth real and durable?

Trailing-12-month revenue declined 70.7% year on year — but the quarterly pace is slowing (+122% → −2%).

1 of the last 4 quarters grew year on year.

Revenue TTM
97bn
−70.7%
Latest quarter YoY
−2%
slowing

What is driving the margin?

▼▼

Net margin fell to −51.44%, losing 73.1pp. The main pressure is SG&A / Revenue rose 35.9pp, outweighing the improvement in Gross margin rose 1.6pp (with lingering pressure from Net financial result / Revenue fell 26.5pp and Other profit / Revenue fell 8.3pp).

Margin is under pressure from multiple sides — temporary and structural components need to be separated to properly assess the risk.

Net Margin
−51.44%
−73.1pp
Gross Margin
12.46%
+1.6pp
SG&A / Revenue
21.66%
+35.9pp
Non-core / Revenue
−35.94%
−34.8pp

TTM YoY · 2025Q2 -> 2026Q2

Financial result share remains high

Even though contribution decreased by 34.8pp, financial result still accounts for 70.3% of PBT — earnings durability should be monitored in coming periods.

Cash Flow

●

Is profit converting into cash?

With leverage safe, cash flow shows the self-funding capacity. Operating cash flow reached 258.8bn against investing cash flow of -265.0bn (annual cash-flow figures for 2025).

Post-investment cash flow was negative +6.2bn. Financing cash flow was negative +5.0bn.

CFO / net income was 1,65 lần.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Earnings Quality

▼

How much income is non-core?

Non-core income reaches 70.3% of pre-tax profit — core earnings are thinner than the headline.

Within that, net financial result at +61.7%, other profit at +8.6% of PBT.

Non-core / PBT
70.3%
high
Net financial / PBT
61.7%
Other profit / PBT
8.6%
02

Is capital being used efficiently?

Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.

Is capital being deployed efficiently?

●

Track how much operating profit the business generates on invested capital.

Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.

Working Capital Efficiency

▼▼

Cash conversion cycle lengthened by 329.0 days versus the same period last year. The main moves came from DIO rose 117.4 days, DSO rose 378.9 days, and DPO rose 167.2 days.

Working capital cycle lengthened mainly due to slower receivables collection — receivables quality needs monitoring.

Cash conversion cycle remains stretched

CCC stands at 639.9 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +378.9 days, pointing to slower receivables turnover.

DuPont

What drives ROE?

Net margin -51.4% -73.1pp
Asset turnover 0.05x -0.12x
Financial leverage 1.21x +0.03x
ROE -3.1% -1.4pp

ROE fell from 4.5% to −3.1% — dragged by net margin and asset turnover.

03

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Leverage & Liquidity

▼▼

Leverage warrants monitoring, with net debt / equity at 0.18x and interest coverage only at −1.37x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 3.2% of debt, and total debt stands at 160.6bn.

Net Debt / Equity
0.18x
+0.10x
Interest Coverage
−1.37x
−4.58x
Cash / Debt
3.2%
−5.6pp
Short-term Debt / Total Debt
100.0%
+84.5pp

TTM YoY · 2025Q2 -> 2026Q2

Interest coverage is thin

Interest coverage is −1.37x, leaving limited room to absorb financing costs.

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Balance Sheet

▼

Capital structure is conservative with low leverage — liabilities at 0.18x equity, net debt at 0.18x equity.

None

Over the last 12 months, working capital absorbed 73.7bn of cash, mainly because of higher receivables and higher inventories. Part of that drag was offset by higher payables.

Research synthesis

What this reporting period is showing

The business is showing a few weaker signals, but the current magnitude is not yet clear enough to conclude that this is a broader weakening phase. Even so, earnings quality still needs closer monitoring because net financial result remains elevated. The main risk still sits in core profitability, with net margin down 73.1 pp.

  • Watchpoint: cash flow is currently keeping pace with accounting earnings, with CFO / net income at 1.65x. Even so, net financial result still accounts for 61.7% of PBT, so the earnings mix still needs monitoring.
  • Key risk: profitability remains under pressure, with trailing-12M net margin at -51.44% after a 73.1pp decline versus the same period last year.

Questions for the next period

  1. Whether revenue stabilizes after a −70,7% YoY decline or keeps falling.

  2. Whether margins hold around the current -51.44% level or narrow again.

  3. Whether operating cash flow holds its 258.8bn (cumulative for 2025) level in upcoming periods or weakens.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio